ArticleHarm reduction journal2021
Recovery capital among people receiving treatment for opioid use disorder with buprenorphine.
Article in Harm reduction journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- The impact of spiritual well-being and social support on substance use treatment outcomes within a sample of predominantly Black/African American adults.Journal of substance use and addiction treatment · 2024Trial
- Using Machine Learning to Predict Features Within Substance Use Disorder Treatment Service Settings That Increase the Likelihood of Positive Treatment Outcomes.Prevention science : the official journal of the Society for Prevention Research · 2026Article
- Correlates of recovery capital among women in jails: Leveraging a dimensional recovery framework.Addiction research & theory · 2025Article
- Exploring the impact of a medication adherence intervention on recovery and mental health outcomes: A secondary analysis of the MAT-PLUS pilot RCT.Drug and alcohol dependence reports · 2025Article
- The silence of opioids-dependent chronic pain patients: A text mining analysis from sex and gender perspective.PloS one · 2025Article
- "Recovery is about change, so you have to change everything": Exploring the evolution of recovery capital among women in substance use disorder treatment.SSM. Qualitative research in health · 2024Article
- Barriers and facilitators for family physicians prescribing opioid agonist therapy in Saskatchewan.Canadian family physician Medecin de famille canadien · 2024Article
- Investigating the role of interpersonal relationships on low-income SUD patients' recovery: a qualitative analysis of various stakeholders in New York State.Addiction research & theory · 2024Article
- The Role of Patient-Reported Social Factors in Promoting Buprenorphine Consistency.Archives of psychiatry (Wilmington, Del.) · 2023Article
- Social determinants of health and emergency department utilization among adults receiving buprenorphine for opioid use disorder.Drug and alcohol dependence reports · 2022Article
- Within Sex Differences from a Clinical Trial of Digital Cognitive Behavioral Therapy for Alcohol Use Disorder Among a Nontreatment Sample.Women's health reports (New Rochelle, N.Y.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundRecovery is a multidimensional process that includes health, quality of life, and citizenship. Recovery capital is a strengths-based concept representing the sum of an individual's resources that support recovery. This study (1) describes recovery capital, (2) examines the relationship between recovery capital and treatment duration, and (3) assesses differences by gender in recovery capital among people receiving medication for opioid use disorder (MOUD).
methodsThis is a secondary data analysis of a cross-sectional study, with survey and medical record review components, conducted with patients recruited from an office-based opioid treatment clinic between July and September 2019. Analyses included participants receiving MOUD with buprenorphine who completed the Brief Assessment of Recovery Capital (BARC-10; n = 130). Univariate analyses explored differences by gender. Multivariate linear regression assessed the relationship between BARC-10 total score and length of current treatment episode.
resultsParticipants were 54.6% women and 67.4% Black with mean age of 42.4 years (SD = 12.3). Mean length of current MOUD treatment was 396.1 days (SD = 245.9). Total BARC-10 scores were high, but participants perceived low community-level resources. Women scored higher than men within the health and purpose recovery dimensions. While length of treatment was not associated with BARC-10 score, experiencing recent discrimination was associated with a significantly lower BARC-10 score.
conclusionsRecovery capital among individuals receiving MOUD was high suggesting that participants have resources to support recovery, but gender differences and prevalent discrimination highlight areas for improved intervention. More work is needed to investigate recovery capital as an alternative treatment outcome to abstinence in outpatient MOUD populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.